Bayer Recalls 6 mL Size Afrin Original Nasal Spray Bottles Due to Risk of Serious Injury or Illness from Child Poisoning; Violates Mandatory Standard for Child-Resistant Packaging

Recall date

April 30, 2026

Source

U.S. Consumer Product Safety Commission (CPSC)

Recall number

26455

Brand / firm

Bayer HealthCare LLC, of Whippany, New Jersey

Sold / distributed

Retailers such as convenience stores and travel hubs including airports from September 2024 to April 2026 for about $7 to $9.

Why it was recalled

The 6 mL nasal sprays contain an imidazoline, which must be in child-resistant packaging or meet the labeling requirements for non-complying packaging, as required by the Poison Prevention Packaging Act. The 6 mL nasal spray's packaging is not child-resistant nor bears the required labeling statement, posing a risk of serious injury or illness from poisoning, if the contents are swallowed by young children.

What was recalled

This recall involves unexpired Travel Size Afrin® Original Nasal Spray 6 mL bottles, with Lot numbers 230361, 240822, 241198, 250066, 250152, 250646, and 250831. These travel size bottles have "Afrin® Original Nasal Spray" and "1/5 FL OZ (6 mL)" printed on a label located on the front of the bottle. It is a six-digit number, followed by the expiration date in following format: "YYYYMMM". No other sizes of Afrin are included in this recall.

What to do

Consumers should immediately secure the recalled bottles out of sight and reach of children and go to the webform posted on www.livewell.bayer.com/afrin-original-spray-recall to begin a request for a refund. Consumers will be asked to take and submit a photo of the product before disposing of it in order to receive a refund.. Follow the official notice for full instructions.